A team of psychiatric providers & clinicians at one outpatient site in the Spokane Valley working
collaboratively to help people with behavioral health issues get better.
Serve the mid-level care gap between traditional outpatient psychiatric care & inpatient facilities.
Supplement lower level outpatient care (such as medication management) or transition out of
inpatient care (such as inpatient psychiatric care, residential facilities, or the ER).
Adults & adolescents whose behavioral healthcare needs are more acute than what may be provided by a traditional outpatient psychiatric provider or outpatient therapist.
Adults & adolescents who would benefit from step down services after an inpatient psychiatric
People suffering from treatment-resistant depression with multiple failed medications.
Esketamine, or Spravato®, is the first nasal spray medication that is a treatment for depression. Combined with an antidepressant, Spravato® is FDA-approved to treat depression and has been clinically shown to improve symptoms of depression over just 4 weeks.